NCT06731348View on ClinicalTrials.gov

Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery

PHASE4Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions

Patient SatisfactionOpioid Use After SurgeryUrogynecologic Surgery

Interventions

DRUG

restricted opioid prescribing

Participants in the restricted opioid prescribing group will receive restricted opioid prescribing after surgery. They will receive 1 tablet of Oxycodone HCl 5mg.

DRUG

standard opioid prescribing

Participants will receive standard opioid prescribing - Oxycodone HCl 5mg x10 tablets for major cases, 5 tablets for minor cases.

Trial Locations (1)

20889

Walter Reed National Military Medical Center, Bethesda

All Listed Sponsors

lead

Walter Reed National Military Medical Center

FED

NCT06731348 - Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery | Biotech Hunter | Biotech Hunter